Treatment of localized vitiligo with targeted broadband UVB phototherapy: a pilot study
Background: Narrowband ultraviolet B (UVB) phototherapy and 308 nm excimer laser have produced encouraging therapeutic results for vitiligo. Repigmentation of various degrees was obtained in different studies. Materials and methods: Twenty‐nine vitiliginous lesions from six patients were treated wit...
Saved in:
| Published in | Photodermatology, photoimmunology & photomedicine Vol. 22; no. 3; pp. 133 - 136 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
Oxford, UK
Blackwell Publishing Ltd
01.06.2006
Blackwell |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0905-4383 1600-0781 |
| DOI | 10.1111/j.1600-0781.2006.00217.x |
Cover
| Abstract | Background: Narrowband ultraviolet B (UVB) phototherapy and 308 nm excimer laser have produced encouraging therapeutic results for vitiligo. Repigmentation of various degrees was obtained in different studies.
Materials and methods: Twenty‐nine vitiliginous lesions from six patients were treated with targeted, broadband UV‐B phototherapy. UV fluences were started at 50% of the minimal erythema dose, then increased gradually. Treatments were carried out twice weekly for 12 weeks.
Results: Some degree of repigmentation occurred in all subjects. Responses varied among the different anatomic locations, with acral lesions achieving the least improvement. Onset of repigmentation was as early as 3 weeks of treatment in some subjects. Treatments were well tolerated, with only minimal erythema and hyperpigmentation.
Limitations: This study was carried out in a smaller number of patients with skin types III and IV. The irradiation device was a broadband UVB device, and thus the results may not be similar to those obtained from a more monochromatic system such as an excimer laser.
Conclusions: Targeted broadband UVB is an efficacious and safe modality for the treatment of localized vitiligo. |
|---|---|
| AbstractList | Narrowband ultraviolet B (UVB) phototherapy and 308 nm excimer laser have produced encouraging therapeutic results for vitiligo. Repigmentation of various degrees was obtained in different studies.BACKGROUNDNarrowband ultraviolet B (UVB) phototherapy and 308 nm excimer laser have produced encouraging therapeutic results for vitiligo. Repigmentation of various degrees was obtained in different studies.Twenty-nine vitiliginous lesions from six patients were treated with targeted, broadband UV-B phototherapy. UV fluences were started at 50% of the minimal erythema dose, then increased gradually. Treatments were carried out twice weekly for 12 weeks.MATERIALS AND METHODSTwenty-nine vitiliginous lesions from six patients were treated with targeted, broadband UV-B phototherapy. UV fluences were started at 50% of the minimal erythema dose, then increased gradually. Treatments were carried out twice weekly for 12 weeks.Some degree of repigmentation occurred in all subjects. Responses varied among the different anatomic locations, with acral lesions achieving the least improvement. Onset of repigmentation was as early as 3 weeks of treatment in some subjects. Treatments were well tolerated, with only minimal erythema and hyperpigmentation.RESULTSSome degree of repigmentation occurred in all subjects. Responses varied among the different anatomic locations, with acral lesions achieving the least improvement. Onset of repigmentation was as early as 3 weeks of treatment in some subjects. Treatments were well tolerated, with only minimal erythema and hyperpigmentation.This study was carried out in a smaller number of patients with skin types III and IV. The irradiation device was a broadband UVB device, and thus the results may not be similar to those obtained from a more monochromatic system such as an excimer laser.LIMITATIONSThis study was carried out in a smaller number of patients with skin types III and IV. The irradiation device was a broadband UVB device, and thus the results may not be similar to those obtained from a more monochromatic system such as an excimer laser.Targeted broadband UVB is an efficacious and safe modality for the treatment of localized vitiligo.CONCLUSIONSTargeted broadband UVB is an efficacious and safe modality for the treatment of localized vitiligo. Narrowband ultraviolet B (UVB) phototherapy and 308 nm excimer laser have produced encouraging therapeutic results for vitiligo. Repigmentation of various degrees was obtained in different studies. Twenty-nine vitiliginous lesions from six patients were treated with targeted, broadband UV-B phototherapy. UV fluences were started at 50% of the minimal erythema dose, then increased gradually. Treatments were carried out twice weekly for 12 weeks. Some degree of repigmentation occurred in all subjects. Responses varied among the different anatomic locations, with acral lesions achieving the least improvement. Onset of repigmentation was as early as 3 weeks of treatment in some subjects. Treatments were well tolerated, with only minimal erythema and hyperpigmentation. This study was carried out in a smaller number of patients with skin types III and IV. The irradiation device was a broadband UVB device, and thus the results may not be similar to those obtained from a more monochromatic system such as an excimer laser. Targeted broadband UVB is an efficacious and safe modality for the treatment of localized vitiligo. Background: Narrowband ultraviolet B (UVB) phototherapy and 308 nm excimer laser have produced encouraging therapeutic results for vitiligo. Repigmentation of various degrees was obtained in different studies. Materials and methods: Twenty‐nine vitiliginous lesions from six patients were treated with targeted, broadband UV‐B phototherapy. UV fluences were started at 50% of the minimal erythema dose, then increased gradually. Treatments were carried out twice weekly for 12 weeks. Results: Some degree of repigmentation occurred in all subjects. Responses varied among the different anatomic locations, with acral lesions achieving the least improvement. Onset of repigmentation was as early as 3 weeks of treatment in some subjects. Treatments were well tolerated, with only minimal erythema and hyperpigmentation. Limitations: This study was carried out in a smaller number of patients with skin types III and IV. The irradiation device was a broadband UVB device, and thus the results may not be similar to those obtained from a more monochromatic system such as an excimer laser. Conclusions: Targeted broadband UVB is an efficacious and safe modality for the treatment of localized vitiligo. Background: Narrowband ultraviolet B (UVB) phototherapy and 308 nm excimer laser have produced encouraging therapeutic results for vitiligo. Repigmentation of various degrees was obtained in different studies. Materials and methods: Twenty‐nine vitiliginous lesions from six patients were treated with targeted, broadband UV‐B phototherapy. UV fluences were started at 50% of the minimal erythema dose, then increased gradually. Treatments were carried out twice weekly for 12 weeks. Results: Some degree of repigmentation occurred in all subjects. Responses varied among the different anatomic locations, with acral lesions achieving the least improvement. Onset of repigmentation was as early as 3 weeks of treatment in some subjects. Treatments were well tolerated, with only minimal erythema and hyperpigmentation. Limitations: This study was carried out in a smaller number of patients with skin types III and IV. The irradiation device was a broadband UVB device, and thus the results may not be similar to those obtained from a more monochromatic system such as an excimer laser. Conclusions: Targeted broadband UVB is an efficacious and safe modality for the treatment of localized vitiligo. |
| Author | Asawanonda, Pravit Korkij, Wiwat Charoenlap, Marisa |
| Author_xml | – sequence: 1 givenname: Pravit surname: Asawanonda fullname: Asawanonda, Pravit organization: Division of Dermatology, Department of Medicine, Chulalongkorn University, Bangkok, Thailand – sequence: 2 givenname: Marisa surname: Charoenlap fullname: Charoenlap, Marisa organization: Division of Dermatology, Department of Medicine, Chulalongkorn University, Bangkok, Thailand – sequence: 3 givenname: Wiwat surname: Korkij fullname: Korkij, Wiwat organization: Division of Dermatology, Department of Medicine, Chulalongkorn University, Bangkok, Thailand |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17776720$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/16719866$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkdFu0zAUhi00xLrCKyDfwF2y48SxUySQxsTaSdNWiY0ibizHcVaXNA62y9o9_VxaisQN-MaW_X3HR-c_QUed7TRCmEBK4jpdpIQBJMBLkmYALAXICE_Xz9Dg8HCEBjCCIqF5mR-jE-8XAEApkBfomDBORiVjAzS7dVqGpe4Ctg1urZKtedQ1_mmCac29xQ8mzHGQ7l6HeF05K-tKdjW--_IR93MbbJhrJ_vNOyxxb1obsA-revMSPW9k6_Wr_T5Edxefbs8nydXN-PL87CpRNC94UinIGq5GmjOuJEgqqSobTfIM8rooVJ2VGWGyoayiLCsIJTyjutCUMs6B1vkQvd3V7Z39sdI-iKXxSret7LRdecFKAA6jLIKv9-CqWupa9M4spduI36OIwJs9IH2cQuNkp4z_w3Eee4xtDdGHHaec9d7pRigTZDC2C06aVhAQ24zEQmyjENsoxDYj8SsjsY4Fyr8KHP74t_p-pz6YVm_-2xPTyXQaT9FPdr7xQa8PvnTfBeM5L8Tseiy-ff46m47JRFzkT_0PttM |
| CitedBy_id | crossref_primary_10_4103_ejdv_ejdv_14_22 crossref_primary_10_1111_j_1365_4632_2011_05257_x crossref_primary_10_1007_s10103_014_1568_6 crossref_primary_10_1111_pde_13098 crossref_primary_10_1080_09546634_2018_1544409 crossref_primary_10_1111_j_1365_2230_2009_03712_x crossref_primary_10_1111_j_1365_4632_2009_03928_x crossref_primary_10_5021_ad_2008_20_3_107 crossref_primary_10_1089_pho_2009_2637 crossref_primary_10_3892_etm_2017_4381 crossref_primary_10_1111_ced_12441 crossref_primary_10_1111_j_1365_2133_2009_09461_x crossref_primary_10_1097_00042728_200810000_00021 |
| Cites_doi | 10.1159/000065845 10.1001/archderm.139.5.581 10.1111/j.1365-2133.2001.04381.x 10.1001/archderm.1997.03890480045006 10.1046/j.1468-3083.2002.00407.x 10.1067/mjd.2001.114752 10.1067/S0190-9622(03)01484-1 10.1067/mjd.2002.126250 10.1046/j.1365-4362.2003.01997.x 10.1001/archderm.139.5.571 10.1046/j.1365-2133.2001.04248.x 10.1111/j.1365-2230.2004.01477.x 10.1001/archderm.138.12.1613 |
| ContentType | Journal Article |
| Copyright | 2006 INIST-CNRS |
| Copyright_xml | – notice: 2006 INIST-CNRS |
| DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1111/j.1600-0781.2006.00217.x |
| DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1600-0781 |
| EndPage | 136 |
| ExternalDocumentID | 16719866 17776720 10_1111_j_1600_0781_2006_00217_x PHPP217 ark_67375_WNG_ZSXWPG1H_F |
| Genre | article Clinical Trial Journal Article |
| GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 123 1OB 1OC 29O 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAKAS AAMMB AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFS ACGOF ACMXC ACPOU ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFEBI AFFPM AFGKR AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AIACR AIDQK AIDYY AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 R.K ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WVDHM WXI WXSBR XG1 YFH ZGI ZZTAW ~IA ~WT AAYXX CITATION IQODW AAHHS ACCFJ AEEZP AEQDE AEUQT AFPWT AIWBW AJBDE CGR CUY CVF ECM EIF NPM WRC 7X8 |
| ID | FETCH-LOGICAL-c4357-bc02f7c9e767ca0a4a4c8fe13203d55cd28216af46b4625141724e5e4467704d3 |
| IEDL.DBID | DR2 |
| ISSN | 0905-4383 |
| IngestDate | Fri Jul 11 03:35:57 EDT 2025 Wed Feb 19 01:55:07 EST 2025 Mon Jul 21 09:16:15 EDT 2025 Thu Apr 24 22:57:46 EDT 2025 Wed Oct 01 01:51:54 EDT 2025 Sun Sep 21 06:22:50 EDT 2025 Sun Sep 21 06:18:59 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | Skin disease Ultraviolet radiation Vitiligo Pigmentation disorder Treatment Dermatology UVB radiation targeted UVB ultraviolet Localized Phototherapy |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4357-bc02f7c9e767ca0a4a4c8fe13203d55cd28216af46b4625141724e5e4467704d3 |
| Notes | ark:/67375/WNG-ZSXWPG1H-F istex:8AAB690E42820F5532620C11F2ADC4490FABF5EC ArticleID:PHPP217 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
| PMID | 16719866 |
| PQID | 68007092 |
| PQPubID | 23479 |
| PageCount | 4 |
| ParticipantIDs | proquest_miscellaneous_68007092 pubmed_primary_16719866 pascalfrancis_primary_17776720 crossref_citationtrail_10_1111_j_1600_0781_2006_00217_x crossref_primary_10_1111_j_1600_0781_2006_00217_x wiley_primary_10_1111_j_1600_0781_2006_00217_x_PHPP217 istex_primary_ark_67375_WNG_ZSXWPG1H_F |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | June 2006 |
| PublicationDateYYYYMMDD | 2006-06-01 |
| PublicationDate_xml | – month: 06 year: 2006 text: June 2006 |
| PublicationDecade | 2000 |
| PublicationPlace | Oxford, UK |
| PublicationPlace_xml | – name: Oxford, UK – name: Oxford – name: England |
| PublicationTitle | Photodermatology, photoimmunology & photomedicine |
| PublicationTitleAlternate | Photodermatol Photoimmunol Photomed |
| PublicationYear | 2006 |
| Publisher | Blackwell Publishing Ltd Blackwell |
| Publisher_xml | – name: Blackwell Publishing Ltd – name: Blackwell |
| References | Parsad D, Saini R, Nagpal R. Calcipotriol in vitiligo: a preliminary study. Pediatric Dematol 1999; 16 : 317-320. Menchini G, Tsoureli-Nikita E, Hercogova J. Narrow-band UV-B micro-phototherapy: a new treatment for vitiligo. J Eur Acad Dermatol Venereol 2003; 17 : 171-177. Grimes PE, Soriano T, Dytoc MT. Topical tacrolimus for repigmentation of vitiligo. J Am Acad Dermatol 2002; 47 : 789-791. Taneja A, Trehan M, Taylor C. 308-nm excimer laser for the treatment of localized vitiligo. Int J Dermatol 2003; 42 : 658-662. Baltas E, Csoma Z, Ignacz F, Dobozy A, Kemeny L. Treatment of vitiligo with the 308-nm xenon chloride excimer laser. Arch Dermatol 2002; 138 : 1619-1620. Baltas E, Nagy P, Bonis B, et al. Repigmentation of localized vitiligo with the xenon chloride laser. Br J Dermatol 2001; 144 : 1266-1267. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol 1997; 133 : 1525-1528. Natta R, Somsak T, Wisuttida T, Laor L. Narrowband UltraViolet B radiation therapy for recalcitrant vitiligo in Asians. J Am Acad Dermatol 2003; 49 : 473-476. Lepe V, Moncada B, Castanedo-Cazares JP, Torres-Alvarez MB, Ortiz CA, Torres-Rubalcava AB. A double-blind randomized trial of 0.1% tacrolimus vs. 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol 2003; 139 : 581-585. Passeron T, Ostovari N, Zakaria W, et al. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. Arch Dermatol 2004; 140 : 1065-1069. Scherschun L, Kim JJ, Lim HW. Narrow-band UltraViolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol 2001; 44 : 999-1003. Leone G, Iacovelli P, Paro Vidolin A, Picardo M. Monochromatic excimer light 308 nm in the treatment of vitiligo: a pilot study. J Eur Acad Derm Venereol 2003; 17 : 531-537. Chiaverini C, Passeron T, Ortonne JP. Treatment of vitiligo by topical calcipotriol. J Eur Acad Dermatol Venereol 2002; 16 : 137-138. Kawalek AZ, Spencer JM, Phelps RG. Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study. Dermatol Surg 2004; 30 : 130-135. Travis LB, Weinberg JM, Silverberg NB. Successful treatment of vitiligo with 0.1% tacrolimus ointment. Arch Dermatol 2003; 139 : 571-574. Ameen M, Exarchou V, Chu AC. Topical calcipotriol as monotherapy and in combination with psoralen plus UltraViolet A in the treatment of vitiligo. Br J Dermatol 2001; 145 : 476-479. Tanghetti EA. Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of a prospective patient series. Cutis 2003; 71 : 158-162. Esposito M, Soda R, Costanzo A, Chimenti S. Treatment of vitiligo with the 308 nm excimer laser. Clin Exp Dermatol 2004; 29 : 133-137. Spencer JM, Nossa R, Ajmeri J. Treatment of vitiligo with the 308-nm excimer laser: a pilot study. J Am Acad Dermatol 2002; 46 : 727-731. Smith DA, Tofte SJ, Hanifin JM. Repigmentation of vitiligo with topical tacrolimus. Dermatology 2002; 205 : 301-303. Mayoral FA, Gonzalez C, Shah NS, Arciniegas C. Repigmentation of vitiligo with pimecrolimus cream: a case report. Dermatology 2003; 207 : 322-323. 2002; 16 2001; 144 2002; 47 2004; 30 2001; 145 2003; 207 2003; 139 2004; 29 1999; 16 2002; 46 2004; 140 1997; 133 2002; 205 2003; 49 2002; 138 2003; 17 2003; 71 2001; 44 2003; 42 e_1_2_5_14_2 e_1_2_5_13_2 e_1_2_5_9_2 e_1_2_5_16_2 Tanghetti EA. (e_1_2_5_7_2) 2003; 71 e_1_2_5_8_2 e_1_2_5_15_2 e_1_2_5_6_2 e_1_2_5_5_2 e_1_2_5_12_2 Menchini G (e_1_2_5_20_2) 2003; 17 e_1_2_5_4_2 e_1_2_5_11_2 Kawalek AZ (e_1_2_5_21_2) 2004; 30 e_1_2_5_2_2 e_1_2_5_18_2 Spencer JM (e_1_2_5_17_2) 2002; 46 Parsad D (e_1_2_5_3_2) 1999; 16 Mayoral FA (e_1_2_5_10_2) 2003; 207 Leone G (e_1_2_5_19_2) 2003; 17 Passeron T (e_1_2_5_22_2) 2004; 140 |
| References_xml | – reference: Smith DA, Tofte SJ, Hanifin JM. Repigmentation of vitiligo with topical tacrolimus. Dermatology 2002; 205 : 301-303. – reference: Parsad D, Saini R, Nagpal R. Calcipotriol in vitiligo: a preliminary study. Pediatric Dematol 1999; 16 : 317-320. – reference: Passeron T, Ostovari N, Zakaria W, et al. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. Arch Dermatol 2004; 140 : 1065-1069. – reference: Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol 1997; 133 : 1525-1528. – reference: Ameen M, Exarchou V, Chu AC. Topical calcipotriol as monotherapy and in combination with psoralen plus UltraViolet A in the treatment of vitiligo. Br J Dermatol 2001; 145 : 476-479. – reference: Scherschun L, Kim JJ, Lim HW. Narrow-band UltraViolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol 2001; 44 : 999-1003. – reference: Mayoral FA, Gonzalez C, Shah NS, Arciniegas C. Repigmentation of vitiligo with pimecrolimus cream: a case report. Dermatology 2003; 207 : 322-323. – reference: Kawalek AZ, Spencer JM, Phelps RG. Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study. Dermatol Surg 2004; 30 : 130-135. – reference: Lepe V, Moncada B, Castanedo-Cazares JP, Torres-Alvarez MB, Ortiz CA, Torres-Rubalcava AB. A double-blind randomized trial of 0.1% tacrolimus vs. 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol 2003; 139 : 581-585. – reference: Leone G, Iacovelli P, Paro Vidolin A, Picardo M. Monochromatic excimer light 308 nm in the treatment of vitiligo: a pilot study. J Eur Acad Derm Venereol 2003; 17 : 531-537. – reference: Chiaverini C, Passeron T, Ortonne JP. Treatment of vitiligo by topical calcipotriol. J Eur Acad Dermatol Venereol 2002; 16 : 137-138. – reference: Spencer JM, Nossa R, Ajmeri J. Treatment of vitiligo with the 308-nm excimer laser: a pilot study. J Am Acad Dermatol 2002; 46 : 727-731. – reference: Taneja A, Trehan M, Taylor C. 308-nm excimer laser for the treatment of localized vitiligo. Int J Dermatol 2003; 42 : 658-662. – reference: Grimes PE, Soriano T, Dytoc MT. Topical tacrolimus for repigmentation of vitiligo. J Am Acad Dermatol 2002; 47 : 789-791. – reference: Tanghetti EA. Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of a prospective patient series. Cutis 2003; 71 : 158-162. – reference: Esposito M, Soda R, Costanzo A, Chimenti S. Treatment of vitiligo with the 308 nm excimer laser. Clin Exp Dermatol 2004; 29 : 133-137. – reference: Natta R, Somsak T, Wisuttida T, Laor L. Narrowband UltraViolet B radiation therapy for recalcitrant vitiligo in Asians. J Am Acad Dermatol 2003; 49 : 473-476. – reference: Baltas E, Csoma Z, Ignacz F, Dobozy A, Kemeny L. Treatment of vitiligo with the 308-nm xenon chloride excimer laser. Arch Dermatol 2002; 138 : 1619-1620. – reference: Travis LB, Weinberg JM, Silverberg NB. Successful treatment of vitiligo with 0.1% tacrolimus ointment. Arch Dermatol 2003; 139 : 571-574. – reference: Baltas E, Nagy P, Bonis B, et al. Repigmentation of localized vitiligo with the xenon chloride laser. Br J Dermatol 2001; 144 : 1266-1267. – reference: Menchini G, Tsoureli-Nikita E, Hercogova J. Narrow-band UV-B micro-phototherapy: a new treatment for vitiligo. J Eur Acad Dermatol Venereol 2003; 17 : 171-177. – volume: 16 start-page: 317 year: 1999 end-page: 320 article-title: Calcipotriol in vitiligo publication-title: a preliminary study – volume: 30 start-page: 130 year: 2004 end-page: 135 article-title: Combined excimer laser and topical tacrolimus for the treatment of vitiligo publication-title: a pilot study – volume: 205 start-page: 301 year: 2002 end-page: 303 article-title: Repigmentation of vitiligo with topical tacrolimus publication-title: Dermatology – volume: 133 start-page: 1525 year: 1997 end-page: 1528 article-title: Treatment of vitiligo with UV‐B radiation vs topical psoralen plus UV‐A publication-title: Arch Dermatol – volume: 71 start-page: 158 year: 2003 end-page: 162 article-title: Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo publication-title: results of a prospective patient series – volume: 138 start-page: 1619 year: 2002 end-page: 1620 article-title: Treatment of vitiligo with the 308‐nm xenon chloride excimer laser publication-title: Arch Dermatol – volume: 49 start-page: 473 year: 2003 end-page: 476 article-title: Narrowband UltraViolet B radiation therapy for recalcitrant vitiligo in Asians publication-title: J Am Acad Dermatol – volume: 144 start-page: 1266 year: 2001 end-page: 1267 article-title: Repigmentation of localized vitiligo with the xenon chloride laser publication-title: Br J Dermatol – volume: 139 start-page: 581 year: 2003 end-page: 585 article-title: A double‐blind randomized trial of 0.1% tacrolimus vs. 0.05% clobetasol for the treatment of childhood vitiligo publication-title: Arch Dermatol – volume: 207 start-page: 322 year: 2003 end-page: 323 article-title: Repigmentation of vitiligo with pimecrolimus cream publication-title: a case report – volume: 16 start-page: 137 year: 2002 end-page: 138 article-title: Treatment of vitiligo by topical calcipotriol publication-title: J Eur Acad Dermatol Venereol – volume: 17 start-page: 171 year: 2003 end-page: 177 article-title: Narrow‐band UV‐B micro‐phototherapy publication-title: a new treatment for vitiligo – volume: 140 start-page: 1065 year: 2004 end-page: 1069 article-title: Topical tacrolimus and the 308‐nm excimer laser publication-title: a synergistic combination for the treatment of vitiligo – volume: 47 start-page: 789 year: 2002 end-page: 791 article-title: Topical tacrolimus for repigmentation of vitiligo publication-title: J Am Acad Dermatol – volume: 46 start-page: 727 year: 2002 end-page: 731 article-title: Treatment of vitiligo with the 308‐nm excimer laser publication-title: a pilot study – volume: 29 start-page: 133 year: 2004 end-page: 137 article-title: Treatment of vitiligo with the 308 nm excimer laser publication-title: Clin Exp Dermatol – volume: 139 start-page: 571 year: 2003 end-page: 574 article-title: Successful treatment of vitiligo with 0.1% tacrolimus ointment publication-title: Arch Dermatol – volume: 44 start-page: 999 year: 2001 end-page: 1003 article-title: Narrow‐band UltraViolet B is a useful and well‐tolerated treatment for vitiligo publication-title: J Am Acad Dermatol – volume: 42 start-page: 658 year: 2003 end-page: 662 article-title: 308‐nm excimer laser for the treatment of localized vitiligo publication-title: Int J Dermatol – volume: 17 start-page: 531 year: 2003 end-page: 537 article-title: Monochromatic excimer light 308 nm in the treatment of vitiligo publication-title: a pilot study – volume: 145 start-page: 476 year: 2001 end-page: 479 article-title: Topical calcipotriol as monotherapy and in combination with psoralen plus UltraViolet A in the treatment of vitiligo publication-title: Br J Dermatol – ident: e_1_2_5_5_2 doi: 10.1159/000065845 – ident: e_1_2_5_9_2 doi: 10.1001/archderm.139.5.581 – volume: 17 start-page: 531 year: 2003 ident: e_1_2_5_19_2 article-title: Monochromatic excimer light 308 nm in the treatment of vitiligo publication-title: a pilot study – ident: e_1_2_5_2_2 doi: 10.1111/j.1365-2133.2001.04381.x – ident: e_1_2_5_12_2 doi: 10.1001/archderm.1997.03890480045006 – volume: 16 start-page: 317 year: 1999 ident: e_1_2_5_3_2 article-title: Calcipotriol in vitiligo publication-title: a preliminary study – volume: 140 start-page: 1065 year: 2004 ident: e_1_2_5_22_2 article-title: Topical tacrolimus and the 308‐nm excimer laser publication-title: a synergistic combination for the treatment of vitiligo – volume: 71 start-page: 158 year: 2003 ident: e_1_2_5_7_2 article-title: Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo publication-title: results of a prospective patient series – volume: 46 start-page: 727 year: 2002 ident: e_1_2_5_17_2 article-title: Treatment of vitiligo with the 308‐nm excimer laser publication-title: a pilot study – volume: 207 start-page: 322 year: 2003 ident: e_1_2_5_10_2 article-title: Repigmentation of vitiligo with pimecrolimus cream publication-title: a case report – ident: e_1_2_5_4_2 doi: 10.1046/j.1468-3083.2002.00407.x – ident: e_1_2_5_11_2 doi: 10.1067/mjd.2001.114752 – ident: e_1_2_5_14_2 doi: 10.1067/S0190-9622(03)01484-1 – ident: e_1_2_5_6_2 doi: 10.1067/mjd.2002.126250 – ident: e_1_2_5_13_2 doi: 10.1046/j.1365-4362.2003.01997.x – ident: e_1_2_5_8_2 doi: 10.1001/archderm.139.5.571 – volume: 17 start-page: 171 year: 2003 ident: e_1_2_5_20_2 article-title: Narrow‐band UV‐B micro‐phototherapy publication-title: a new treatment for vitiligo – ident: e_1_2_5_15_2 doi: 10.1046/j.1365-2133.2001.04248.x – ident: e_1_2_5_18_2 doi: 10.1111/j.1365-2230.2004.01477.x – ident: e_1_2_5_16_2 doi: 10.1001/archderm.138.12.1613 – volume: 30 start-page: 130 year: 2004 ident: e_1_2_5_21_2 article-title: Combined excimer laser and topical tacrolimus for the treatment of vitiligo publication-title: a pilot study |
| SSID | ssj0004401 |
| Score | 1.8633637 |
| Snippet | Background: Narrowband ultraviolet B (UVB) phototherapy and 308 nm excimer laser have produced encouraging therapeutic results for vitiligo. Repigmentation of... Background: Narrowband ultraviolet B (UVB) phototherapy and 308 nm excimer laser have produced encouraging therapeutic results for vitiligo. Repigmentation of... Narrowband ultraviolet B (UVB) phototherapy and 308 nm excimer laser have produced encouraging therapeutic results for vitiligo. Repigmentation of various... |
| SourceID | proquest pubmed pascalfrancis crossref wiley istex |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 133 |
| SubjectTerms | Adult Biological and medical sciences Dermatology Erythema - etiology Female Humans Male Medical sciences Middle Aged Pigmentary diseases of the skin Pilot Projects Skin Pigmentation - radiation effects targeted UVB ultraviolet Ultraviolet Rays Ultraviolet Therapy - adverse effects Ultraviolet Therapy - methods vitiligo Vitiligo - therapy |
| Title | Treatment of localized vitiligo with targeted broadband UVB phototherapy: a pilot study |
| URI | https://api.istex.fr/ark:/67375/WNG-ZSXWPG1H-F/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1600-0781.2006.00217.x https://www.ncbi.nlm.nih.gov/pubmed/16719866 https://www.proquest.com/docview/68007092 |
| Volume | 22 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1600-0781 dateEnd: 20241001 omitProxy: true ssIdentifier: ssj0004401 issn: 0905-4383 databaseCode: ABDBF dateStart: 20020801 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 0905-4383 databaseCode: DR2 dateStart: 19980101 customDbUrl: isFulltext: true eissn: 1600-0781 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0004401 providerName: Wiley-Blackwell |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF6hIiEulHfNo-wBcXNkx_vkVhBphNQqgoZEXFbr9S5YiewocVDbX8-OHwlGPVSIm7XW-DGe8c7zG4TeWuc4sywJDXEmJDaSobSMhlII6phOCXMQhzw7Z-Mp-Tyn87b-CXphGnyIXcANNKP-X4OC63TTV3IGXdFcxF1OwZvXA7An44TWGdsveyQpQupJyJGMaAjonP2inhsv1Nup7gLTL6FyUm8881wz9eIms7Rv5dbb1OgQLboXbKpTFoNtlQ7M9V_Yj_-HAw_Rg9aaxSeN-D1Cd2zxGN07a_P1T9Dsoqtjx6XD9b6ZX9sM_8qrfJn_KDGEgXFTje6X03Wps1QXGZ5--4BXP8uq7Q-7eo81XuXLssI1Hu5TNB19uvg4DttRDl4GEsrD1ERDx420nHGjI000McJZ6N9OMkpN5j2_mGlHmJcOb3IRb1cRS613VjmPSJY8QwdFWdgjhOWQM0O8lyONP-2MENoQ45hMhbV-NUC8-2zKtDjnMG5jqf7wdzzfFPANpnBCXZ_nm7oMULyjXDVYH7egeVdLxo5ArxdQK8epmp2fqu9f57PJaTxWowAd90RnfwcOgErDKEBvOllSXsUhb6MLW243igkAZZLDAD1vRGxPy3gsBWMBYrWg3Pqx1WQ8mfijF_9K-BLdb4JREI96hQ6q9da-9uZZlR7XivcbgaAoww |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Jb9NAFB6hVgIu7IsLtHNA3BzZyXgWbmypgSaKICERl9F4PEOtRnaUOqj01zPPS4JRDxXiZo31vDy_53nr9xB6aaxl1NCBr4nVPjGB8IWhkS84jyxVCaEW4pCjMY1n5NMiWjTjgKAXpsaH2AbcQDOq_zUoOASku1pOoS2a8bBNKjj7uucMyn1I14GWvv-yw5IipJqFHIgg8gGfs1vWc-WVOnvVPrD9Amon1bljn63nXlxlmHbt3GqjGt5Fy_YV6_qUs96mTHr68i_0x__Eg3voTmPQ4je1BN5HN0z-AN0cNSn7h2g-bUvZcWFxtXVmlybFP7MyW2Y_CgyRYFwXpLvlZF2oNFF5imff3uLVaVE2LWK_XmOFV9myKHEFifsIzYYfpu9iv5nm4MRgEDE_0UHfMi0Mo0yrQBFFNLcGWrgHaRTp1Dl_IVWWUCcgzuoizrQiJjLOX2UsIOngMdrLi9w8RVj0GdXEOTpCu9NWc6400ZaKhBvjVj3E2u8mdQN1DhM3lvIPl8fxTQLfYBAnlPY5vskLD4VbylUN93ENmleVaGwJ1PoMyuVYJOfjY_n962I-OQ5jOfTQYUd2dndggKnUDzx01AqTdFoOqRuVm2JzLikHXCbR99CTWsZ2tJSFglPqIVpJyrUfW07iycQdHfwr4RG6FU9HJ_Lk4_jzM3S7jk1BeOo52ivXG_PCWWtlclhp4W8W5Szf |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9swDCaGFih22Xur92h1GHZzYCeyZO22V5o9GgRbswS7CLIsbUYCO0idoeuvn-hHMg89FMNuhgz6QZPWR4r6CPDcWMuZYQNfU6t9agLhC8MiX8RxZJlKKLOYhzwds9GUfphH86b-CffC1PwQ24Qbekb1v0YHX6W26-QMd0XzOGzXFBy87jk8uU-ZC7YQIH3eUUlRWrVCDkQQ-UjP2a3qufJKnalqH7V-gaWT6txpz9ZtL67CpV2YW81Tw9uwaN-wLk9Z9DZl0tOXf5E__h8V3IFbDZwlr2r7uws3TH4PDk6bBfv7MDtrC9lJYUk1cWaXJiU_szJbZt8LgnlgUpeju-FkXag0UXlKpl9fk9WPomw2iP16SRRZZcuiJBUh7gOYDt-dvRn5TS8HZwSDiPuJDvqWa2E441oFiiqqY2twA_cgjSKdutAvZMpS5szDYS7qgBU1kXHRKucBTQcPYS8vcnMIRPQ509SFOUK701bHsdJUWyaS2Bg36gFvP5vUDdE59ttYyj8CHqc3iXrDNpxY2Of0Ji88CLeSq5rs4xoyLyrL2Aqo9QKL5XgkZ-MT-e3LfDY5CUdy6MFRx3R2d-DIqNQPPDhubUk6H8eFG5WbYnMuWYysTKLvwaPaxHayjIciZswDVhnKtR9bTkaTiTt6_K-Cx3AweTuUn96PPz6Bm3ViCnNTT2GvXG_MMwfVyuSo8sHfVUErjg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Treatment+of+localized+vitiligo+with+targeted+broadband+UVB+phototherapy%3A+a+pilot+study&rft.jtitle=Photodermatology%2C+photoimmunology+%26+photomedicine&rft.au=Asawanonda%2C+Pravit&rft.au=Charoenlap%2C+Marisa&rft.au=Korkij%2C+Wiwat&rft.date=2006-06-01&rft.issn=0905-4383&rft.volume=22&rft.issue=3&rft.spage=133&rft_id=info:doi/10.1111%2Fj.1600-0781.2006.00217.x&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0905-4383&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0905-4383&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0905-4383&client=summon |